LifeSci Nerd Out [#3]

Welcome to this week’s edition of my Life Science Weekly Reads - a curated stack of the biggest industry moves, fundraises, innovations, and perspectives shaping biotech globally and in India 🌍🔬

🔬 Diagnostics & Innovations

Exact Sciences Rolls Out Cancerguard Multi-Cancer Blood Test
Exact Sciences expands its portfolio in early cancer detection with Cancerguard, a non-invasive blood test that detects multiple cancer types early, aiming to improve patient outcomes through easier screening solutions.
🔗 Read more

---

⚖️ Regulatory Drama

FDA Misinterpreted Efficacy Data, Prompting DMD Therapy Rejection – Capricor Claims
Capricor Therapeutics, a biotech company, challenges the FDA’s decision to reject its cell therapy for Duchenne Muscular Dystrophy, citing misinterpretation of efficacy data. This highlights the ongoing tension between innovation and regulatory scrutiny in biotech.
🔗 Read more

---

🚀 Venture Capital & Funding

Venture Capital for Life Scientists – Chapter 1
A must-read for life science founders, this practical guide explains the VC world through the eyes of a scientist, covering fundraising, deal terms, and investor expectations.
🔗 Read more

RA Capital's Triple-Comma Queens
A fascinating profile on the women leaders at RA Capital reshaping venture capital in life sciences, offering lessons on diversity and investment strategy.
🔗 Read more

India Needs a Deeptech Fund, Not Just a Startup Fund
A strong argument for India to establish dedicated deeptech funds, focusing on long-term scientific innovation rather than early-stage consumer-focused startups.
🔗 Read more

---

🧬 Research & Science

Fluctuating DNA Methylation Tracks Cancer Evolution at Clinical Scale
A groundbreaking Nature study demonstrates how DNA methylation changes can be used to monitor cancer progression in real-time, potentially revolutionizing personalized treatment strategies.
🔗 Read more

---

🇮🇳 India Pharma & Agri-Tech

GST Council’s 56th Meeting: A Pivotal Development for India’s Pharma Sector
The latest GST council meeting introduces critical changes impacting the pharma industry’s tax and regulatory environment, shaping future business strategies in India.
🔗 Read more

ICL and BioPrime Partner to Tackle Phosphorus and Zinc Deficiency in Indian Soils
An important collaboration addressing micronutrient deficiencies in Indian agriculture, advancing sustainable farming practices and improving crop yields in the long term.
🔗 Read more

---

That wraps up this week’s stack. The lifescience ecosystem is clearly accelerating in India and globally, and these fundraises, alliances, and tech innovations are reshaping how the future of science is made.

👉 If you’re curious about any of these topics or want to suggest articles for next week, drop me a comment or DM.

See you next week <3

---

If you are someone who is interested/building/an expert in the Life Science startup ecosystem in India and/or the US, I would love to connect on LinkedIn or Instagram. Every couple of weeks, I highlight founder stories or talk about the infrastructure for life science in India.